0001193125-26-106114
SEC filingPetco Health and Wellness Company, Inc. (WOOF) reported total net sales of $5.96 billion for fiscal year 2025 (ending January 31, 2026), with gross profit of $2.31 billion. The company generated operating income of $120.4 million and consolidated net income of $9.1 million. Key financial metrics include a gross margin of 38.8% and operating margin of 2.0%. The company maintained strong operating cash flow of $314.1 million, with net cash from operations exceeding capital expenditures. The balance sheet shows total assets of $5.17 billion, total liabilities of $4.01 billion, and stockholders' equity of $1.16 billion. The company ended the year with $256.7 million in cash and cash equivalents.
Petco Health and Wellness Company, Inc. reported total net sales of $5.96 billion for fiscal year 2025 (ending January 31, 2026). The company achieved gross profit of $2.31 billion, representing a gross margin of 38.8%. Operating income was $120.4 million, resulting in an operating margin of 2.0%. After accounting for interest expense of $131.2 million, interest income of $6.3 million, loss on partial extinguishment of debt of -$565K, income from equity method investees of $20.4 million, and income tax expense of $6.3 million, the company reported consolidated net income of $9.1 million. Net income attributable to Class A and B-1 common stockholders was also $9.1 million.
The company reported total net sales of $5.96 billion for the fiscal year. The document does not provide segment breakdown, geographic mix, or specific growth drivers beyond the aggregate revenue figure. No product versus service revenue breakdown is provided in the available data. The XBRL data shows total net sales as the primary revenue metric without further segmentation.
The company maintained a gross margin of 38.8% on total net sales of $5.96 billion and cost of sales of $3.66 billion. Operating margin was 2.0% based on operating income of $120.4 million. Selling, general and administrative expenses totaled $2.18 billion. The company reported no goodwill impairment for the period. Interest expense of $131.2 million significantly impacted pre-tax results, resulting in a loss before income taxes and income from equity method investees of -$5.0 million.
The company generated strong operating cash flow of $314.1 million, driven by net income of $9.1 million and significant non-cash adjustments including depreciation and amortization of $196.7 million and non-cash operating lease costs of $411.8 million. Investing activities used $124.6 million, primarily for fixed assets ($127.1 million). Financing activities used $101.7 million, with $201.0 million in debt borrowings offset by $95.2 million in debt repayments. The balance sheet shows total assets of $5.17 billion, including current assets of $1.02 billion (cash: $256.7M, inventories: $590.2M). Total liabilities were $4.01 billion, including $1.49 billion in senior secured credit facilities and $1.37 billion in operating lease liabilities. Stockholders' equity was $1.16 billion with accumulated deficit of -$1.14 billion.
The document content provided does not include management discussion, guidance, strategic priorities, or risk factors beyond the basic financial statements. The available data consists solely of financial statement information without forward-looking commentary or outlook statements. No management guidance or strategic priorities are disclosed in the provided filing content.